Carregant...
Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
We performed post-mortem studies on two patients with advanced Parkinson’s disease 8 and10 years following AAV2-neurturin (CERE120) gene therapy, the longest post-mortem trophic factor gene therapy cases reported to date. CERE120 was delivered to the putamen bilaterally in one case (10 years post-su...
Guardat en:
| Publicat a: | Brain |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089653/ https://ncbi.nlm.nih.gov/pubmed/32203581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa020 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|